I am an Associate Director of Market Access Strategy at Novartis, where I led the strategic pull-through and new product launch for FABHALTA (iptacopan), for paroxysmal nocturnal hemoglobinuria (PNH), an ultra-rare disease. With over 20 years of experience in the healthcare industry, I have a strong background in hematology, oncology, and bone marrow transplantation, as well as market access, population health, quality and patient safety, and performance improvement. As a certified nurse practitioner and clinical nurse specialist, I leverage my clinical knowledge and expertise to develop and execute innovative access and engagement solutions for healthcare systems and payer accounts. I have a Lean Six Sigma Green Belt certification and apply lean principles and tools to optimize processes and outcomes. I am also passionate about developing high-performing teams, driving cultural change, and exploring new opportunities for delivering care to patients and providers.